Sort of on the same topic, maybe some on this page could discuss the wisdom of theracour conveying to nnvc a right of first refusal for the intellectual property it has licensed.
From nnvc's standpoint, it's always better to have such a right than not. What about from theracour's side? What are the cons? What issues arise from dr. Diwan being an owner on both sides of that transaction?
News 
Market Data 
Discover 
AI
